Drug Testing Locations - Kiawah Island, SC

Drug Testing in Kiawah Island, SC

Kiawah Island, South Carolina Statistics

In Kiawah Island, Charleston County, over 10% of adults reported illicit drug use in the past month.

Charleston County reported a 15% increase in opioid-related overdoses in 2022.

The overdose death rate in Charleston County was 25 per 100,000 residents in 2021.

Kiawah Island, Charleston County, saw 150 drug-related arrests in the last recorded year.

Substance abuse treatment admission in Charleston County increased by 12% in 2022.

Fentanyl was involved in 70% of overdose deaths in Charleston County in 2021.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in Kiawah Island, SC & Drug Testing Policies

Employers in Kiawah Island, SC, typically adhere to strict drug testing policies to maintain a safe work environment. Many local businesses conduct pre-employment as well as random drug screenings in accordance with guidelines provided by the Society for Human Resource Management. These policies help deter drug use among employees, ensuring workplace safety.

Companies on Kiawah Island often partner with occupational health services to conduct testing and provide assistance programs. This approach supports those struggling with substance issues and aligns with state regulations following the Occupational Safety and Health Administration (OSHA) standards. Employers prioritize the health and well-being of their workforce through comprehensive policies and supportive services.

Government Efforts with Drug Problems in Kiawah Island, SC

In Kiawah Island, SC, government efforts to combat drug abuse involve collaborative initiatives between local and state agencies. The South Carolina Department of Alcohol and Other Drug Abuse Services provides resources and support programs aimed at prevention and treatment initiatives. These efforts aim to create a safe environment while reducing the availability of controlled substances in Charleston County.

Local law enforcement in Kiawah Island works closely with the South Carolina Law Enforcement Division (SLED) to tackle drug distribution channels. This partnership has led to increased patrols and community outreach programs, educating residents about the risks associated with drug use and offering paths to recovery.

Local Drug Busts & News in Kiawah Island, SC

Recent drug busts in Kiawah Island, SC, highlight ongoing concerns about narcotics trafficking in the area. In a significant operation last year, local law enforcement, in collaboration with the Charleston County Sheriff's Office, seized substantial quantities of illegal substances. This operation disrupted a major supply chain, showcasing the effectiveness of coordinated efforts in tackling drug distribution.

Community meetings and awareness events have been frequently organized by local authorities to educate the public about the dangers of drug abuse. These events often feature guest speakers from the healthcare sector and law enforcement, providing residents with valuable information on recognizing and addressing substance abuse issues.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in Kiawah Island, SC. Trusted by employers nationwide for accurate results and exceptional service.

South Carolina DOT/Non DOT Physicals

South Carolina Vision Tests

South Carolina Audiograms

South Carolina Respirator Fit Tests

South Carolina Lift Tests

South Carolina Background Checks

Clinical Testing Services

TB Testing in SC

Diabetes Testing in SC

Infectious Disease Testing in SC

Sickle Cell Anemia Testing in SC

Women/Men's Health Testing in SC

Resources & Citations

South Carolina Department of Alcohol and Other Drug Abuse Services

Just Plain Killers

Foundations Recovery Network

Cornerstone

LRADAC Behavioral Health Center

Palmetto Addiction Recovery Center

The Gateway House

FAVOR Upstate

Drug Testing Near Kiawah Island, SC

Ravenel, SC

Bear Swamp, SC

Edisto Island, SC

Meggett, SC

North Charleston, SC

Charleston, SC

Shell Point, SC

Riverview, SC

James Island, SC

Rockville, SC

Seabrook Island, SC

Johns Island, SC

Folly Beach, SC

Frequently Asked Questions

Customer Reviews